52.47USD-4.83%Mkt Cap: 1.52B USDP/E: —Last update: 2026-06-01
AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States. The company's products include Rosnilimab, a selectiv…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.52B USD
Enterprise Value1.61B USD
Revenue (TTM)232.39M USD
Gross Profit103.61M USD
Net Income (TTM)-13.23M USD
Revenue/Share8.220 USD
Last Price52.47 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees104
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS0327241065
Valuation
P/E (Trailing)—
P/E (Forward)9.55
PEG—
EV/EBITDA38.97
EV/Revenue6.93
P/S6.97
P/B126.81
EPS (TTM)-1.02
EPS (Forward)5.83
52W Range
11.4067% of range72.36
52W High72.36 USD
52W Low11.40 USD
Profitability
Gross Margin44.58%
Oper. Margin-135.53%
EBITDA Margin17.79%
Profit Margin-5.64%
ROE-35.56%
ROA-3.63%
Growth
Revenue Growth-8.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF19.70M USD
CapEx (TTM)87.00K USD
FCF Margin3.58%
FCF Yield0.55%
Net Debt-9.10M USD
Net Debt/EBITDA-0.22
Balance Sheet
Debt/Equity0.38
Current Ratio7.58
Quick Ratio7.49
Book Value/Sh0.4390 USD
Cash/Share9.844 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split15:10
Split DateApr 20, 2026
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)84.45 USD
Target Range66.00 USD – 140.00 USD
# Analysts11
Ownership
Shares Out.29.10M
Float19.55M
Insiders5.74%
Institutions103.58%
Short Interest
Short Ratio6.6d
Short % Float23.77%
Short % Out.16.48%
Shares Short4.80M
Short (prev mo.)4.11M
Technical
SMA 5053.26 (-1.5%)
SMA 20033.01 (+59.0%)
Beta0.48
S&P 52W Chg27.94%
Avg Vol (30d)607.88K
Avg Vol (10d)488.62K
Technical Indicators
RSI (14)41.5
MACD0.4227
MACD Signal2.0131
MACD Hist.-1.5904
BB Upper72.13 USD
BB Middle62.91 USD
BB Lower53.70 USD
BB Width29.29%
ATR (14)3.712 USD
Vol Ratio (20d)0.55x